Neogen Chemicals Third Quarter 2024 Earnings Misses Expectations - Simply Wall St

NEOG Stock  USD 12.04  0.02  0.17%   
Roughly 62% of all Neogen's stockholders are looking to take a long position. The analysis of overall sentiment of trading Neogen stock suggests that some investors are interested at this time. The current market sentiment, together with Neogen's historical and current headlines, can help investors time the market. In addition, many technical investors use Neogen stock news signals to limit their universe of possible portfolio assets.
  
Neogen Chemicals Third Quarter 2024 Earnings Misses Expectations Simply Wall St

Read at news.google.com
Google News at Macroaxis
  

Neogen Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Neogen can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Neogen Fundamental Analysis

We analyze Neogen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neogen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neogen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Neogen is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Neogen Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neogen stock to make a market-neutral strategy. Peer analysis of Neogen could also be used in its relative valuation, which is a method of valuing Neogen by comparing valuation metrics with similar companies.

Peers

Neogen Related Equities

XGNExagen   9.34   
0%
79.0%
SERASera Prognostics   7.33   
0%
62.0%
BNRBurning Rock   6.99   
0%
59.0%
IQVIQVIA Holdings   3.00   
0%
25.0%
RDNTRadNet   1.85   
0%
15.0%
ICLRICON PLC   1.42   
0%
12.0%
MYGNMyriad Genetics   0.83   
0%
7.0%
QGENQiagen NV   0.79   
0%
6.0%
MEDPMedpace Holdings   0.64   
0%
5.0%
FONRFonar   0.20   
0%
1.0%
SHCSotera Health   0.23   
1.0%
0%
ACRSAclaris Therapeutics   11.69   
100.0%
0%

Complementary Tools for Neogen Stock analysis

When running Neogen's price analysis, check to measure Neogen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neogen is operating at the current time. Most of Neogen's value examination focuses on studying past and present price action to predict the probability of Neogen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neogen's price. Additionally, you may evaluate how the addition of Neogen to your portfolios can decrease your overall portfolio volatility.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.